Personalized medicine: Implications for research and policy

被引：0
作者：
Steinke, Douglas [1 ]
Ashcroft, Darren [1 ]
机构：
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Ctr Pharmacoepidemiol & Drug Safety, Manchester, Lancs, England
来源：
JOURNAL OF HEALTH SERVICES RESEARCH & POLICY | 2013年 / 18卷 / 02期
关键词：
D O I：
10.1177/1355819613476276
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 6 条
  • [1] [Anonymous], GUARDIAN
  • [2] Limitations of applying summary results of clinical trials to individual patients - The need for risk stratification
    Kent, David M.
    Hayward, Rodney A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1209 - 1212
  • [3] Personalised medicine: not just in our genes
    Kitsios, Georgios D.
    Kent, David M.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [4] Pirmohamed M., 2012, SCI STRATIFIED MED
  • [5] Personalized medicine: is it a pharmacogenetic mirage?
    Shah, Rashmi R.
    Shah, Devron R.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (04) : 698 - 721
  • [6] Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
    Stanek, E. J.
    Sanders, C. L.
    Taber, K. A. Johansen
    Khalid, M.
    Patel, A.
    Verbrugge, R. R.
    Agatep, B. C.
    Aubert, R. E.
    Epstein, R. S.
    Frueh, F. W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) : 450 - 458
1